Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases ...
Some small IPOs are tentatively scheduled for the short holiday week ahead. Space and defense contractor Karman Holdings (KRMN) priced its upsized IPO above the range to raise $506 million at a $2.9 ...
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
Amgen (NASDAQ: AMGN ) will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m. ET on Wednesday, Feb. 19, 2025. Jean-Charles Soria, senior vice president of oncology within global ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Apptronik, a University of Texas spinout that was quietly building humanoid robots before it became quite so fashionable, on ...
Discover the latest in dental technology as Zug-based vVardis partners with OrbiMed to secure $35 million in financing.
STORZ & BICKEL is redefining vaporization with medical-grade precision. From the Volcano to the VENTY, Jürgen Bickel shares ...
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...
Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...
Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results